Follicular lymphoma (FL), diffuse large B cell lymphoma (DLBCL) and primary central nervous system lymphoma are B cell malignancies. FL and DLBCL have a germinal center origin. We have applied mutational analyses and a novel algorithm for quantifying shape properties of mutational lineage trees to investigate the nature of the diversification, somatic hypermutation and selection processes that affect B cell clones in these malignancies and reveal whether they differ from normal responses. Lineage tree analysis demonstrated higher diversification and mutations per cell in the lymphoma clones. This was caused solely by the longer diversification times of the malignant clones, as their recent diversification processes were similar to those of normal responses, implying similar mutation frequencies. Since previous analyses of antigen-driven selection were shown to yield false positives, we performed a corrected analysis of replacement and silent mutation patterns, which revealed selection against replacement mutations in the framework regions, responsible for the structural integrity of the B cell receptor, but not for positive selection for replacements in the complementary determining regions. Most replacements, however, were neutral or conservative, suggesting that if at all selection operates in these malignancies it is for structural B cell receptor integrity but not for antigen binding.
Introduction
Follicular lymphoma (FL) and diffuse large B cell lymphoma (DLBCL) are B cell malignancies of a germinal center (GC) origin (1, 2) . Primary central nervous system lymphoma (PCNSL) is similar to DLBCL and may also have a GC origin (3) . In FL, the tumor cell population is descended from a single B cell; hence, it was suggested that the establishment of the malignant clone starts with a single B cell, which has presumably undergone the initiating t(14;18) translocation in the bone marrow. The precursor cell has then proliferated in a GC where it underwent the final events leading to malignant transformation (4) . FL cells in follicles were found to be similar to GC cells, showing characteristics resembling the architecture of reactive non-malignant GCs (1, 2) . However, studies show that neoplastic follicles lack the organization and functions typical of reactive GCs and that FL cells may not have retained properties of normal GC B cells (5) . FLs are reported to carry heavily mutated IgV genes. Within the tumor clones, there is also evidence of intraclonal sequence variation, suggesting that somatic hypermutation (SHM) remains active in FL (6) . Additionally, it was proposed that FL cells may, during their malignant growth, still be clonally selected on the basis of the antigen-binding capacity of their B cell receptors (BCRs), as the mutation patterns in the IgV genes of FLs were found to be highly comparable to those in normal antigen-selected B cells (7) . However, this proposition remains to be rigorously addressed.
A possible outcome of indolent, low-grade B cell lymphomas such as FL is the transformation to the more aggressive, high-grade DLBCL. About 30% of all FL cases transform to DLBCL and are associated with poor prognosis (8) . In such transformations, it has been found that the intraclonal diversity in IgV heavy chain sequences in FL is reduced as they become DLBCL, suggesting that the low-grade to high-grade transformation had occurred in a single cell (9) .
DLBCL is a clinically aggressive disease of mature B lymphocytes that infiltrate and destroy the lymph nodes and other tissues. These B cells may be one of several morphological types such as centroblasts, immunoblasts or anaplastic large B cells (10, 11) . DLBCL was found to be a heterogeneous group of diseases comprising either GClike cells exhibiting intraclonal diversity or 'activated-like' cells which do not (9) (10) (11) (12) (13) . The rearranged IgV genes in the GC origin DLBCL type bear mutations that are characteristic of SHM, suggesting that DLBCL arises either from GC B cells or from post-GC B cells (10, 12, 14) . Additionally, antigen selection pressures were deduced from mutation analyses in mutated DLBCL cases (11, 14) . However, this was based on an analysis method that was later shown to yield false positives (15) , and hence, as with FL, this issue still awaits further elucidation.
Both diseases have been shown to exhibit intraclonal heterogeneity: different cells have variable numbers of point mutations in their heavy and light chain IgV genes, typical of SHM in GCs. SHM may be continuous in B cell lymphomas located in a GC-like environment, such as FL and DLBCL, thereby leading to the intraclonal sequence variation (6, 10, 12) . The GC-like malignant cells in FL and GC origin DLBCL seem to always be under the influence of the SHM mechanism (5, 7, 9, 12, 14, 16) .
PCNSLs are highly malignant DLBCLs, which arise in and are confined to the central nervous system (CNS) (3) . A high level of SHM is observed in PCNSLs, with intraclonal variation. There is a biased usage of the V4-34 gene, suggesting a functional role for an antigen or a superantigen. Although these features are characteristic of GC lymphomas, there is no evidence for GC structures in the brain, therefore raising the possibility that the tumor developed in an extracerebral site and migrated to the CNS. B cells are known to cross the blood brain barrier in low numbers. However, there is no priming of the essential CD4+ T cells at the site, suggesting that these B cells have matured elsewhere. A post-GC B cell, which has accumulated in a tumorigenic event, could be stimulated by an antigen in the brain, leading to the final transformation.
Intraclonal variation enables the construction and analysis of clonal lineage trees (also referred to as dendrograms or pedigrees). In a GC, there are usually several different B cell clones. Clonally related cells are identified by their use of the same V (D) and J segments and possessing highly homologous sequences of the complementary determining region 3 (CDR3) of their Ig variable region (V) gene. The differences in Ig genes between the cells belonging to the same clone are the result of SHM. In each division, a cell undergoes on average one Ig gene mutation. Hence, it is possible to analyze the sequences and identify the IgV gene sequence of the original founder B cell. Thus, a lineage tree depicting the relationships between sequences in a clone, in which each node represents a single mutation, can be drawn.
The generation of trees visualizing lineage relationships of B cell mutants in GCs has been used in previous studies to confirm the role of the GC as the location of SHM and to identify lineage relationships between cells from independent GCs (17) or from different tissues (18, 19) . It was also suggested that much information about the dynamics of antigen-driven clonal selection are contained within the shape of the lineage trees deduced from the responding clones (20) . We developed a method of mathematically analyzing lineage trees by measuring their graphical properties (21) . Previous studies demonstrated the usefulness of this method and resulted in new insights regarding GC age and tissuerelated differences (21) (22) (23) , autoimmune diseases (24) and chronic inflammation (25) . Additional bioinformatical methods to study Ig gene diversification include amino acid (AA) substitution counts (26) , which may determine the effect that mutations have on the peptide chain and the final protein product and analyses of the frequencies of replacement (R) and silent (S) mutations (RS analysis) (27, 28) , which provide insights regarding the role of the antigen during clonal outgrowth. We use a modified version of this latter method, in which the flaws of the previous versions are corrected (15) .
In the present study, we used lineage tree and mutation analyses to investigate whether and how the diversification and selection mechanisms in FL, DLBCL and PCNSL differ from normal responses and what is the role they play in these malignancies. The lymphoma clones were found to have higher diversification and mutational histories compared with normal response clones. However, we show here that these differences are likely to be caused by the longer time that the malignant clones have spent diversifying rather than differences in mutation frequencies. R and S mutation patterns demonstrated a stronger selection against R mutations in the lymphoma clones in the framework regions (FR), which are responsible for the structural integrity of the BCR, but not for positive selection for R mutations in the CDRs. However, AA substitution analysis showed that the R mutations in the FRs are mostly conservative or neutral. These findings suggest that if at all selection operates in these malignancies, it is for structural BCR integrity but not for antigen binding.
Methods

Sources of data for analysis
All data sources are listed in Table 1 . FL, DLBCL and PCNSL IgV light and heavy chain sequences from bulk cell suspensions from tumor lymph nodes and tumor specimens, respectively, were provided by McCann et al. (3, 4) and Ottensmeier et al. (10) . All samples were taken at the time of diagnosis. Normal GC IgV heavy chain sequences, obtained from frozen sections of fresh normal spleen and Peyer's patch by micro-dissection, were taken from Banerjee et al. (23) . In the latter study, fresh, histologically normal human spleen was obtained from patients undergoing splenectomy due to trauma and fresh, histologically normal specimens of terminal ileum were obtained from the outer 876 Ig gene diversification in FL, DLBCL and PCNSL margins of surgical resections for carcinoma or from biopsy material taken for routine diagnostics procedures and subsequently found to be normal. Normal peripheral blood (PB) lymphocyte IgV light chain sequences, obtained from frozen samples of PB by total RNA extraction, were the same as used as controls in a previous study by Abraham et al. (29) . Part of the normal PB data included clonally related sequences, while the other part was single sequences. Only the clonal data were used for lineage tree and mutation analyses, while both the clonal and single sequence data were used for mutation analyses. All the normal NP data included only single sequences and were thus not used for the clonal lineage tree analysis. In all clonal data received, the mutated sequences were already arranged into clones. For the PB data group, identification of the rearranged germline (GL) genes by alignment with published human IgV genes was performed using SoDA (32) . All sequences were checked to exclude PCR hybrids.
Lineage tree generation and measurement Lineage tree generation. Lineage tree generation was performed as described in previous work (25) (Fig. 1) . Briefly, a lineage tree is a rooted tree where each node corresponds to an Ig gene sequence. For two nodes X and Y, we say that Y is a child of X if the sequence corresponding to Y is Table 2 . In this example, RootD = 1, minimum root-fork distance (DRSN-min) = 1, minimum fork-fork distance (DASN-min) = 1, minimum path (PL-min) = 4, average outgoing degree (OD-avg) = 2.3 (average of OD values of split nodes 1 and 2, which both have OD = 2, and of split node 4, which has OD = 3), average trunkless path (DLFSN-avg) = 3.4 (average of DLFSN lengths of leaves 7, 8, 9 and 10, which all have DLFSN = 3, and of leaf 13, which has DLFSN = 5).
Ig gene diversification in FL, DLBCL and PCNSL 877 a mutant of the sequence corresponding to X, which differs from X by only one mutation, and is one mutation further than X away from the original (GL) gene, that is the root. The tree depicts the diversification process of a B cell clone at the moment of observation, consisting of Ig sequences of cells that were sampled at that moment. Ancestors that were not sampled could be deduced by sequence alignment. Nodes in the tree can be the root node, leaves (terminal sequences) or internal nodes, which can be either split nodes (branching points) or pass-through nodes. Sampled sequences may appear anywhere on the tree. Multiple alignments with ClustalW (www.ebi.ac.uk/clustalw) were used to align all the sequences from the same clone in order to verify clonal relationships. Ig gene sequences were transformed into mutational lineage trees using our program IgTreeª (33), implementing a distance method-based algorithm that finds the most likely tree with a high probability. The lymphoma tree trunks may contain mutations that had occurred prior to malignant transformation, but the diversified trunks of the trees were most likely created after transformation. Hence, although the trees do not give any temporal information beyond the likelihood of mutation placement, omission of tree trunks allows the examination of the relatively recent clonal diversification processes. This 'trunkless tree analysis' was performed by deletion of the trunk from all trees, assigning the first split node to be the new root. Trees that originally had no trunks were removed from the trunkless analysis, so the data will not be biased, as they did not contain enough information regarding their diversification history.
Lineage tree measurement. All trees were measured using our program MTreeª (21, 22) , implementing a rigorous algorithm for quantifying the shape properties of the trees in terms of graph theory, such as the number of leaves, number of nodes etc. According to this method, defined distances between key tree nodes (root, split nodes or 'forks' and leaves) reflect dynamical features of clonal evolution including the mutation rate of IgV, the affinity between target antigen and the B cell receptor of the Ig clone and antigendriven selection pressure. A thorough statistical analysis that correlated tree characteristics with B cell response dynamic parameters, such as the mutation rate or the selection threshold, using a computer simulation of the humoral immune response (34) , has concluded that seven specific tree characteristics possess the highest correlation values with the biological parameters and are hence most informative. These properties are the minimum root to leaf path length (PL-min or Path-min), the average distance from a leaf to the first split node/fork (DLFSN-avg or Trunkless Pathavg), the average outgoing degree, that is the average number of branches coming out of any node (OD-avg), the root's outgoing degree (RootD or number of branches coming out of the root), minimum distance between adjacent split nodes/forks (DASN-min or fork to fork distance-min), the length of the tree's Trunk (T) and minimum distance from the root to any split node/fork (DRSN-min or root-fork distancemin; Table 2 ). The analysis in the present study has thus focused on these characteristics, excluding T, as explained above.
Statistical analysis.
Comparison between lineage tree characteristics of different data groups was done using the nonparametric Mann-Whitney U-test, as normal distributions (required by tests such as Student's T-test) could not be assumed. To correct for the fact that we perform multiple comparisons (on six different tree properties), we used the FDR method (35) , which uses progressive cutoff values of the test a (=0.05 here) divided by the number of comparisons, that is here we had an interval 0.05/6 ffi 0.0083. Only T was not included in the comparisons in the present study, as explained in Methods.
differences that were found to be significant under this correction were considered as meaningful in our studies.
Ig mutation analyses
The following analyses were performed using computer procedures integrated into our IgTreeª program (33) . Thus, all these analyses are performed 'per tree' in order to count only the true number of appearances of each mutation. In addition, IgTreeª can handle a succession of mutations (gaps or adjacent point mutations) as one mutational event.
The results are subject to the tree structure as created by the program. This is the main difference between our analysis and the mutational analyses routinely published by others, where clonality is often not taken into account and hence many mutations are counted more than once; the latter methods are subject to sampling biases and thus may lead to incorrect conclusions. Three types of mutation analyses were performed: 'mutation targeting motif analysis', 'RS analysis' and 'AA substitution analysis'.
Mutation targeting motif analysis. Mutation targeting motif analysis was based on previous work by Spencer and Dunn-Walters et al. (36) . Briefly, the base composition at positions flanking a mutation (three nucleotides on either side) was determined. For each nucleotide in each position in each type of mutation, a v 2 analysis was performed to check whether the frequency of the nucleotide is significant compared with its theoretical frequency.
RS analysis. R and S mutation analysis methods attempt to measure the extent of selection operating on the diversifying clones. These methods compare the frequencies of R mutations found in different regions in mutated IgV gene sequences to their expected frequency based on codon usage of the GL sequence. The conventional method (27, 28) was shown to give false indications of selection (37, 38) . Therefore, we have used a correction to this method, the focused binomial test, by Hershberg et al. (15) . IgTreeª counts the number of observed mutations (i.e. for all the mutations in each lineage tree) for each clone. The number of observed mutations were pooled for each data group, and the focused binomial formula (15) was then calculated using Matlabª.
AA substitution analysis. AA substitutions were enumerated for each clone as follows. The program receives the clone's multiple alignment file and the appropriate reading frame. For each mutation, the program translates the codon in which the mutation was into the correct AA for both the mutated sequence and its parent sequence, that is the closest split node preceding the mutated sequence (33) .
The AA substitutions were enumerated per clone to avoid counting each mutation-which, according to tree structure, appeared only once in the process-multiple times, as occurs when groups of sequences are analyzed with no regard to clonality. One may argue that this may cause a loss of information on the relative 'quality' of each substitution, as those that positively affect the cell's survival would result in more descendant sequences. However, we have obtained similar results when each mutation was weighted (multiplied) by the number of tree nodes containing this mutation to account for the higher weight of mutations that may have contributed to the success of the corresponding branch of the clone (divided by the total number of nodes in the tree to eliminate effects of sampling on tree size)-data not shown. Additionally, one may argue that the different numbers of clones in each group may skew the results toward showing higher diversity in the groups in which we had a higher number of clonal trees to analyze, that is the lymphoma trees. It was suggested that we divide the total numbers of AA changes for each data set by the number of clones in the data set to yield AA substitutions per clone per data set. However, this would skew the results the opposite way (that is we shall see lower AA change frequencies in the groups which have higher numbers of clones), so we preferred to leave the AA substitution frequencies unscaled. We did, however, calibrate the substitutions in the FR/CDR areas by the length of the CDR or FR regions in each clone to account for differences in region lengths between clones and between FR and CDR lengths in each clone. Distributions of all AA substitutions were compared using a v 2 test.
For each R mutation, the nature of the substitution was assessed according to the extracellular protein substitution matrix (26) . A positive score for a substitution denotes a conservative (commonly known as 'favored') substitution, which preserves most of the physical characteristics of the AA (e.g. both the original and the substituted AAs are positively charged and polar); a score of zero denotes a neutral substitution, that is the AA position shows no preference for substituting with any other AA in particular and a negative score denotes an altering (commonly known as 'disfavored') substitution in which the AA is altered in terms of most physical characteristics (e.g. a hydrophobic AA is substituted with a hydrophilic AA). We refer to favored and disfavored mutations as conservative and altering mutations, respectively, because, in the context of Ig genes, neither the outcome of a conservative mutation is necessarily positive nor is the outcome of an altering mutation necessarily negative; the effects, if any, of the mutation on receptor structure and antigen binding are what determines its value to the cell.
Results
Ig gene sequences from FL, DLBCL and PCNSL patients and normal controls were aligned with the corresponding GL segments. Lineage trees were constructed and drawn for 71 FL, 61 DLBCL, 21 PCNSL, 19 normal GC and 33 normal PB clones. All lymphoma trees (Supplementary Figure 1 is available at International Immunology Online) had longer trunks and were more branched compared with both normal control trees, reflecting the longer mutational history and higher intraclonal diversification, as demonstrated by randomly chosen sample trees shown in Fig. 2 . Qualitatively, it is evident that the diversity is highest in FL trees, lower in DLBCL trees and lowest in PCNSL trees-as seen from the respective decreasing numbers of branches per tree and increasing numbers of trees that consist only of one branch.
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Lymphoma clones have longer diversification history, but similar recent diversification, compared with normal clones
In addition to the qualitative assessments, lineage trees were also quantitatively measured for their characteristics (Table 2 ) to evaluate the extent of clonal diversification and mutation. FL, DLBCL, PCNSL, normal GC and normal PB tree properties were analyzed and compared (Fig. 3A) . All lymphoma trees had significantly longer path (PL-min) and root-fork distance (DRSN-min) but shorter trunkless path (DLFSN-avg) than both groups of normal control trees. PCNSL tree properties were similar to those of DLBCL, with even longer trunk lengths. These results indicate that the lymphoma clones have undergone a longer mutational history than, and ongoing diversification at least as vigorous as, normal control clones. However, this raises the question of whether the longer paths (more mutations per cell) in lymphomas are due to longer times during which these clones have been diversifying or to faster diversification rates.
To address this question, we next set out to examine the recent diversification processes, relative to each response, in FL, DLBCL and PCNSL and whether they differ from those of normal responses. For this purpose, we omitted the tree trunks from all trees and re-analyzed the data. Although this procedure may result in loss of information in some trees, it has the advantage of including only parts of trees that are likely to have been created after the transformation, as explained in Methods. After the exclusion of trees that were only trunks (i.e. had no forks), the new comparison included 69 FL trees, 26 DLBCL trees, 11 PCNSL trees, 19 normal GC trees and 21 normal PB trees. The large number of DLBCL and PCNSL trees that did not have forks could represent clones that were overtaken by a dominant mutant, as a reduction of the heterogeneity of the clone was reported to occur after treatment (9) (10) (11) . Comparisons between trunkless lymphoma and normal trees clearly demonstrated that the prominent differences in path (PL-min) and root-fork distances (DRSN-min) are indeed eliminated after removing the trunk, i.e. when looking only at the recent diversification history (Fig. 3B) . In DLBCL and PCNSL trees, these lengths were even significantly shorter than normal control trees. These results suggest that at a given time point, the extent of clonal diversification is similar (in the case of FL) or even smaller (in the case of DLBCL and PCNSL) than that of normal responses.
All lymphoma trees had a slightly but significantly higher OD-avg and RootD values compared with normal control trees. However, although these values were significantly different between the groups due to low data variability, the values were very close, and thus, these differences are not necessarily biologically significant. This suggests, according to correlations with secondary B cell response dynamic parameters (Table 2 ), similar mutation rates in the lymphoma clones to that in the normal responses. Differences among the lymphoma trees were also observed in the trunkless analysis. Path (PL-min), trunkless path (DLFSN-avg) and root-fork distances (DRSN-min) were significantly longer in FL trees compared with DLBCL and PCNSL trees. These same properties were significantly shorter in PCNSL trees compared with DLBCL trees, suggesting that recent diversification events are highest in FL, followed by DLBCL and finally PCNSL. Thus, it seems that the most aggressive lymphoma diversifies the least.
An analysis of the clonal sequence alignment lengths revealed that the lymphoma clone sequences were longer compared with those of the normal controls (334 6 34 and 258 6 20 in the lymphoma and normal groups, respectively, in the analysis with trunks; 332 6 38 and 251 6 20 in the lymphoma and normal groups in the trunkless analysis). Thus, the analysis of lineage tree properties, scaled by sequence alignment lengths, was performed. The results were similar to the non-scaled results, both in the analysis with and without tree trunks (Supplementary Figure 2 and Table 2 are available at International Immunology Online).
Differences between FL heavy and light chain trees
Multiple alignments of FL, DLBCL and PCNSL clones revealed that the heavy chain sequences were longer and more mutated compared with the light chain sequences (data not shown), as has been found by others (5, (39) (40) (41) (42) . A comparison between heavy and light chain lineage tree properties revealed that FL heavy chain trees were significantly longer [i.e. longer root-fork distance (DRSNmin) and path (PL-min)] and more branched (i.e. longer OD-avg and RootD, the number of branches coming out of the root; Supplementary Figure 3 is available at International Immunology Online). However, as these differences may have been influenced by the differences in sequence lengths, we scaled the tree properties by means of division by the sequence alignment length for each clone. The differences observed were not eliminated by the scaling. A paired analysis was performed, where only heavy and light chains from the same patient were analyzed as above. This comparison, also performed with scaling by sequence length, did not eliminate the differences either (Supplementary Table 3 is available at International Immunology Online).
In light of this, we first performed comparisons between FL, DLBCL, PCNSL and normal controls separately for light and heavy chain trees (data not shown). However, as both heavy and light chain comparisons produced similar results, we grouped the light and heavy chain trees in all data groups, where possible, and compared them with the clonal normal control data available. These results, reported below, Comparison between trunkless FL, DLBCL, PCNSL, normal GC and normal PB. As the tree trunk represents past diversification processes (i.e. clonal history), removing tree trunk allows the detection of differences in the recent diversification process. Here, PL-min and DRSN-min are no longer significantly longer in the lymphoma trees but similar (in FL) or even significantly shorter (in DLBCL and PCNSL) than the normal control trees. The significantly higher OD-avg values in FL, DLBCL and PCNSL trees compared with both normal trees are now more noticeable. *, Significant differences between FL/DLBCL/PCNSL and normal GC; #, significant differences between FL/DLBCL/ PCNSL and normal PB;^, significant differences between FL and DLBCL (presented on the FL group in the figure); $, significant differences between FL and PCNSL (presented on the PCNSL group in the figure) ; &, significant differences between PCNSL and DLBCL (presented on the PCNSL group in the figure) and %, significant differences between normal GC and normal PB (presented on the normal GC group in the figure). P-values for comparisons are given in Supplementary Table 1 (available at International Immunology Online). All differences are significant under the FDR correction.
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were similar to the previous separate comparisons performed.
Lymphoma mutation frequencies are similar to those in normal controls
Mutations from each nucleotide and the transition-transversion mutation ratios, calculated as percentages from the total number of mutations for each group, were examined in FL, DLBCL, PCNSL and normal control clones. The lymphoma groups exhibited mutation frequencies similar to the normal control groups, with similar frequencies of mutations from C and G nucleotides and an A over T bias (Fig. 4A) . In addition, transition mutations were more common than transversion mutations in all groups, resembling the expected ratios normally observed in SHM (43) (Fig. 4B) . Similar results were observed in the analysis of trunkless trees (Supplementary Figure 4 and Table 4 are available at International Immunology Online).
Lymphoma mutation targeting motifs are similar to those in normal controls
The analysis of DNA motifs around mutated nucleotides in IgV genes has aided in revealing many aspects concerning the SHM mechanism induced by the enzyme activationinduced cytidine deaminase (AID). Studies show that AIDtriggered mutations from G/C nucleotides occur in RGYW/ WRCY (R = A/G, Y = C/T and W = A/T) motifs while mutations from A/T nucleotides occur in WA/TW motifs (6) (7) (8) (9) (10) 39) . DNA sequence motif targets for SHM have not been thoroughly investigated in diseases, including lymphomas. Recent publications report that FL, splenic marginal zone lymphoma and multiple myeloma mutations are targeted to the RGYW/WRCY motif (11, 13) . In this study, we counted the nucleotides in the six positions flanking each mutated nucleotide in all lineage trees in each data group. For each position, the excess or paucity of each nucleotide was quantified and the significance level of each of the mutated nucleotide frequencies compared with its theoretical frequency was calculated, as explained in Methods. In a comparison between FL, DLBCL, PCNSL and normal controls, mutational motifs reported in the literature were observed in all groups (Supplementary Figure 5 is available at International Immunology Online). Similar results were observed in motif analysis of trunkless trees. In addition, no differences were observed in comparisons between FL, DLBCL and PCNSL light and heavy chains (data not shown). This implies that the SHM mechanism introduces the mutations to IgV genes into the same targeting motifs in FL, DLBCL and PCNSL as in normal controls.
Analysis of RS analysis
Many studies attempted to evaluate the extent of selection on IgV genes using the calculation of the ratio of observed R and S mutations compared with the respective values estimated for non-selected, random mutations of the specific GL gene used. It was assumed that selection was indicated when the R:S ratio of the observed mutations was higher than the R:S ratio expected under random conditions in the CDRs or lower in the FRs (27, 28) . However, these methods, previously used to evaluate selection in various types of lymphomas (7, (44) (45) (46) (47) (48) (49) (50) , were shown to yield false indications of selection (37, 38) . Hence, all previously reported conclusions based on comparison of R:S ratios to those predicted under previous models of random mutation-such as the previous reports on assumed 'positive antigen-driven selection' in lymphomas (11, 14) -are erroneous. One should not compare R:S ratios to those predicted from the faulty models. Recently, a correction to the conventional method, the 'focused' binomial test, was offered and verified by Hershberg et al. 5 . Analysis of R and S mutations (with trunks). For each data group analyzed, the 'focused binomial test' (15) was used to calculate the significance of the differences in the frequencies of observed R mutations in the FRs and CDRs relative to the expected frequency under the null hypothesis of no selection. Indications of positive (green) and negative (red) selection for/against R mutations are marked for the FRs/CDRs; significant P-values (<0.05) are indicated in the relevant boxes.
In the FRs, all lymphoma groups showed a significantly strong negative selection against R mutations, with very low P-values, whereas in all normal controls, there were signs of weak positive selection for R mutations. However, these latter mutations are mostly of a conservative or neutral nature, as demonstrated in the AA substitution analysis below. In the CDRs, all groups demonstrated negative selection against R mutations. The normal GC group failed to show the expected positive selection for R mutations in the CDRs. This may be due to the small number of sequences sampled and small number of trees in these controls. The normal NP group showed similar non-significant or low significance of positive and negative selection for R mutations in the CDRs and FRs. These results suggest a strong negative selection against R mutations in the FRs of these lymphomas and may indicate the importance of the structural areas (FRs) rather than the CDRs of these lymphoma Ig genes, as discussed below. The analysis of trunkless trees yielded similar results (Supplementary Figure 6 is available at International Immunology Online).
AA substitutions are similar in lymphoma and normal control clones AA substitutions were enumerated for all data set clones, as shown in Fig. 6 . FL and DLBCL clones demonstrated significantly higher frequencies of AA substitution compared with both groups of normal control productive clones (GC and PB), due to the higher total numbers of mutations in these clones. The same differences were preserved when we calibrated all mutation numbers by the number of clones (data not shown). Each mutation was also enumerated in the FRs and CDRs separately, and the nature of the substitution was assessed. Surprisingly, most R mutations in all data sets were located in the FRs rather than CDRs (62, 79, 56, 76, 73 and 69% in the FL, DLBCL, PCNSL, normal GC, PB and NPs, respectively, out of total R mutations). However, most of these were either conservative or neutral (85, 86, 92, 79, 83 and 81% in the FL, DLBCL, PCNSL, normal GC, PB and NP groups, respectively, out of total R mutations in the FRs). Similar results were obtained in both lymphoma and normal groups. Occurrences of altering mutations were found mostly in the NP sequences and lymphoma clones, and these were not targeted to a specific region. The analysis of trunkless trees yielded similar results (Supplementary Figure  7 is available at International Immunology Online).
Discussion
In this study, we applied our algorithms for construction and quantification of lineage trees, as well as additional methods for mutation analyses, to Ig gene sequence data from FL, DLBCL, PCNSL and normal control B cell clones in an attempt to elucidate the details of the clonal histories, diversification and mutation processes that have affected these lymphomas.
As the current study focused on B cell lymphomas undergoing continuous division and Ig gene diversification processes (5, 7, 9-12, 16, 51, 52) , we chose to interpret lineage tree measurements based on the correlation results from secondary and not primary immune response simulations (Table 2) . Lineage tree drawings demonstrated a high intraclonal diversity in the lymphoma clones compared with the normal control clones. In addition, all lymphoma tree trunks were longer compared with those of normal trees, suggesting that the diversification process has been ongoing for a longer period of time. Indeed, quantitative analysis of lineage tree characteristics showed that the lymphoma trees had longer PLs and longer root-fork distances (DRSNs).
Assuming that mutations in normal or malignant tree trunks may also include a clone's pre-transformation history and hence may or may not be relevant for this analysis, we removed the trunks to reveal only differences in the recent diversification processes between lymphoma and normal control trees. Although the exact point in time in which the recent development has started, relative to sampling time, cannot be assessed, this method of removing the trunk does enable us to compare between all clones, focusing on the aspect of recent diversification events. Surprisingly, PLs (PL-min) and root-fork distances (DRSN-min) were found to be similar (in FL trees) or even significantly shorter (in DLBCL and PCNSL trees) compared with normal control trees. This suggests that the extent of recent diversification in these lymphomas is similar to or even lower than that of normal responses and that the differences observed may be derived from the longer diversification times and not from a change in the mutation rate. The shorter lengths observed in DLBCL and PCNSL may be a result of a lower diversification process in these diseases compared with FL. Similarly, these PCNSL tree lengths were significantly shorter compared with DLBCL trees.
The average outgoing degree (OD-avg) of FL, DLBCL and PCNSL trees was slightly larger than that of normal control trees, especially in trunkless trees, but the values were similar. A statistical analysis correlating tree properties with B cell response dynamic parameters (34) showed that ODavg is inversely correlated with the mutation rate (Table 2) , further suggesting that the mutation rate in the lymphoma clones is similar to that in normal clones. The high tumor burdens usually observed in lymphomas may be a result of the long times these clones spend mutating in the lymph nodes rather than a result of a higher mutation rate. In addition, the trunkless analysis showed that RootD values were similar to (in FL trees) or significantly higher than (in DLBCL and PCNSL trees) normal control trees, also representing the accumulation of a large number of mutations after transformation.
In principle, the number of mutations observed should directly depend on division rate, mutation rate per division and length of time from the beginning of the clone's development. Since the targeting motifs and distributions of mutations in the lymphoma sequences were similar to those in the control sequences and since the SHM is already almost as fast as it can be in the control sequences, it is unlikely that the mutation rate is higher in the lymphomas than in the controls. On the other hand, the lymphoma trees were much larger than the normal GCs analyzed as controls. Therefore, either the division rate or the overall clone growth time is larger in the lymphomas than the controls. In low-grade lymphomas such as FL, the division rate is probably not larger Ig gene diversification in FL, DLBCL and PCNSL 883 884 Ig gene diversification in FL, DLBCL and PCNSL than normal (53, 54) , while in high-grade lymphomas such as DLBCL and PCNSL, it is (54, 55). The differences between the lymphoma types are, however, probably balanced at least in part by the fact that faster growing tumors would be diagnosed earlier and the samples are taken at diagnosis. Thus, it is most likely that the overall diversification periodmeasured in number of divisions-is higher in lymphomas than in controls and is responsible for the long trunks of the corresponding trees and to their large sizes.
FL light versus heavy chain lineage tree analyses yielded differences in tree branching and PLs, implying longer mutational history in the heavy chains, as observed by others (5, (39) (40) (41) (42) . However, the differences between groups in light chains and heavy chains were similar, and hence, we grouped the light and heavy chain trees in all data groups, where possible, and compared them with the clonal normal control data available. Additionally, an analysis of trunkless trees, which examined the recent diversification history, eliminated the differences in tree lengths between the heavy and light chains.
Note that the standard deviations in measured tree properties are often very high, regardless of the number of trees included in the measurement, because the mutation process is highly stochastic and hence always generates a high degree of intrinsic variation in the data, which is seen even when large numbers of lineage trees are analyzed. Because of these limitations, we also subjected the data to additional mutational analyses.
Analysis of SHM mutations demonstrated similar frequencies in the lymphoma and normal controls (Fig. 4) . SHM targeting motifs showed that the lymphoma clones were mutated at the same motifs as the normal clones (Supplementary Figure 5 is available at International Immunology Online), which are also identical to the motifs from normal response reported in the literature (52, 56) .
As previously published assessments of antigen-driven selection in lymphomas were based on a method that was shown to yield false positives, the corrected method to analyze R and S mutations was used in this study (15) . The results-which are contrary to the expectations formed by publications based on the old faulty R:S method-show a strong negative selection against R mutations in the lymphoma clones but not in the normal clones. These results raise the hypothesis that stronger selection forces act on the lymphoma clones and are directed against modifications in specific areas in the receptor gene-the FRs. This suggests that the selection may not be acting for binding to a certain specific antigen in these malignancies (through the CDRs) and hence allows the survival of cells possessing all sorts of receptors as long as the structural integrity (the FRs) of the BCR is preserved. Lymphoma clones may receive survival signals through the BCR (57), as do normal B cells, and hence, the preservation of the BCR structural integrity may be important to maintaining these signals. Indeed, it has been previously shown that FL cells acquire N-glycosylation sites in IgV regions during SHM (58) . These sites seem to be positively selected, by interaction with mannose receptor-like elements, and thus may have a role in supporting the survival of lymphoma cells in the GC, bypassing the need for an antigen.
Consistent with the results of the R:S analysis, AA substitution analysis revealed that most R mutations in the FRs in the lymphoma clones were either conservative or neutral. This mutation pattern was also observed in the normal clones and may be attributed to the natural evolution of Ig genes, which have been reported to possess a biased codon usage and nucleotide positioning, such that C / T mutations, rendered by AID, result in a minimum of nonconservative AA replacements, in both the FRs and CDRs (59) . Nevertheless, the NP sequences and the FL and DLBCL clones showed slightly higher numbers of altering mutations than the control clones in both the FRs and CDRs. This would argue that, even if there is selection for receptor functional integrity in the lymphomas, it is weaker than in the controls.
In summary, lineage tree drawings and analyses showed that FL, DLBCL and PCNSL clones are subject to higher diversification and have longer mutational histories compared with normal responses. However, this difference seemed to be caused only by the amount of time that these malignant clones have spent diversifying, as the recent diversification processes were found to be similar to or lower than those in normal responses. Mutation rates were found to be similar or even lower in the lymphoma clones in the lineage tree analysis. The corrected R and S mutation patterns showed a stronger selection against R mutations in CDRs, and for R mutations in FRs, in these lymphomas compared with normal controls. However, along with the high frequency of postmutation AAs and the fact that the FR R mutations in the lymphoma clones were mostly conservative or neutral, this suggests that if at all selection operates on the clones of these malignancies, it is only for the integrity of the BCR but not for antigen binding.
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